The following adjustment was made today on Novartis (NVS). All prices include IB commissions.
| Criteria | Value |
|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 10 |
| Fair Value Estimate | $71.00 |
| Target Buy Price | $56.80 |
| Target Margin of Safety | 20.00% |
| Actual Buy Price | $55.00 |
| Actual Margin of Safety | 20.29% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|
| 3/19/2012 | NVS | Continued Trade | STO 1 May12 57.50 Call @ 0.59 | | | $58.97 |
Current Position Summary
| Cost Basis | ($5,500.00) |
| Income Generated | $137.94 |
| Percent Income Generated | 2.51% |
| Annualized Income Generated | 10.64% |
| Net Profit If Assigned | $387.94 |
| Percent Return If Assigned | 7.05% |
| Annualized Return If Assigned | 29.94% |
| Days Held to Expiration | 86 days |
Trade History
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|
| 2/22/2012 | NVS | CSP Margin Used | CSP 100 NVS @ 55.00 | | ($5,500.00) | |
| 2/22/2012 | NVS | Initial Put Option | STO 1 Mar12 55.00 Put @ 0.79 | Exercised | | $78.97 |
| 3/16/2012 | NVS | CSP Margin Returned | CSP 100 NVS @ -55.00 | | $5,500.00 | |
| 3/16/2012 | NVS | Stock Assigned | EX 1 Mar12 55.00 Put @ -55.00 | | ($5,500.00) | |
| 3/19/2012 | NVS | Continued Trade | STO 1 May12 57.50 Call @ 0.59 | | | $58.97 |
| 5/18/2012 | NVS | | Totals | | ($5,500.00) | $137.94 |
| DTE | 86 | | Percent Income/Annualized | | 2.51% | 10.64% |
